Total Payments
$107,002
2024 Payments
$22,248
Companies
5
Transactions
137
Medicare Patients
142
Medicare Billing
$11,426
Payment Breakdown by Category
Other$71,586 (66.9%)
Consulting$18,960 (17.7%)
Travel$12,502 (11.7%)
Food & Beverage$3,955 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $71,586 | 27 | 66.9% |
| Consulting Fee | $18,960 | 5 | 17.7% |
| Travel and Lodging | $12,502 | 40 | 11.7% |
| Food and Beverage | $3,955 | 65 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $106,670 | 131 | $0 (2024) |
| ABBVIE INC. | $173.50 | 3 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $121.31 | 1 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $22.81 | 1 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $14.35 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,248 | 30 | Neurocrine Biosciences, Inc. ($22,248) |
| 2023 | $16,385 | 25 | Neurocrine Biosciences, Inc. ($16,322) |
| 2022 | $42,688 | 42 | Neurocrine Biosciences, Inc. ($42,563) |
| 2021 | $19,038 | 24 | Neurocrine Biosciences, Inc. ($19,038) |
| 2020 | $6,220 | 9 | Neurocrine Biosciences, Inc. ($6,220) |
| 2019 | $301.18 | 6 | Neurocrine Biosciences, Inc. ($278.37) |
| 2018 | $121.31 | 1 | Sunovion Pharmaceuticals Inc. ($121.31) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $120.85 | General |
| Category: Neuropsychiatry | ||||||
| 06/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,763.00 | General |
| Category: Neuropsychiatry | ||||||
| 06/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $140.00 | General |
| Category: Neuropsychiatry | ||||||
| 06/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $65.66 | General |
| Category: Neuropsychiatry | ||||||
| 05/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $68.08 | General |
| Category: Neuropsychiatry | ||||||
| 05/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $41.82 | General |
| Category: Neuropsychiatry | ||||||
| 05/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: Neuropsychiatry | ||||||
| 05/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neuropsychiatry | ||||||
| 05/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,038.00 | General |
| Category: Neuropsychiatry | ||||||
| 05/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,763.00 | General |
| Category: Neuropsychiatry | ||||||
| 05/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $570.90 | General |
| Category: Neuropsychiatry | ||||||
| 05/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $342.29 | General |
| Category: Neuropsychiatry | ||||||
| 05/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $166.49 | General |
| Category: Neuropsychiatry | ||||||
| 05/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $148.73 | General |
| Category: Neuropsychiatry | ||||||
| 05/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $136.33 | General |
| Category: Neuropsychiatry | ||||||
| 05/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $58.72 | General |
| Category: Neuropsychiatry | ||||||
| 05/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $25.67 | General |
| Category: Neuropsychiatry | ||||||
| 05/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: Neuropsychiatry | ||||||
| 05/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Consulting Fee | Cash or cash equivalent | $6,800.00 | General |
| Category: Neuropsychiatry | ||||||
| 04/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $269.35 | General |
| Category: Neuropsychiatry | ||||||
| 04/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $45.36 | General |
| Category: Neuropsychiatry | ||||||
| 04/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $37.15 | General |
| Category: Neuropsychiatry | ||||||
| 04/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $35.10 | General |
| Category: Neuropsychiatry | ||||||
| 04/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Neuropsychiatry | ||||||
| 04/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $16.74 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 80 | 208 | $38,631 | $10,204 |
| 2021 | 1 | 16 | 64 | $2,648 | $192.00 |
| 2020 | 3 | 46 | 123 | $11,018 | $1,030 |
Total Patients
142
Total Services
395
Medicare Billing
$11,426
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 51 | $17,482 | $5,000 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 25 | 58 | $13,746 | $3,840 | 27.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 18 | 23 | $4,259 | $725.99 | 17.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 76 | $3,144 | $638.40 | 20.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 16 | 64 | $2,648 | $192.00 | 7.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 15 | $3,554 | $541.36 | 15.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 14 | 87 | $3,579 | $259.44 | 7.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 18 | 21 | $3,885 | $228.95 | 5.9% |
About Dr. Alex Orten, M.D
Dr. Alex Orten, M.D is a Family Medicine healthcare provider based in Anchorage, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518912849.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alex Orten, M.D has received a total of $107,002 in payments from pharmaceutical and medical device companies, with $22,248 received in 2024. These payments were reported across 137 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($71,586).
As a Medicare-enrolled provider, Orten has provided services to 142 Medicare beneficiaries, totaling 395 services with total Medicare billing of $11,426. Data is available for 3 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Psychiatry
- Location Anchorage, AK
- Active Since 05/24/2006
- Last Updated 12/20/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1518912849
Products in Payments
- INGREZZA (Drug) $106,654
- VRAYLAR (Drug) $173.50
- LATUDA (Drug) $121.31
- AUSTEDO (Drug) $22.81
- ABILIFY ASIMTUFII (Drug) $14.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Anchorage
Mary Foland, Md, MD
Family Medicine — Payments: $18,521
Family Medicine $18,521
Ms. Ilona Farr, M.d, M.D
Family Medicine — Payments: $17,505
Family Medicine $17,505
Eric Miknich, Md, MD
Family Medicine — Payments: $15,412
Family Medicine $15,412
Bruce Kiessling, Md, MD
Family Medicine — Payments: $7,178
Family Medicine $7,178
Dr. Allison Kelliher, M.d, M.D
Family Medicine — Payments: $6,210
Family Medicine $6,210
Dr. Kenneth Moll, Md, MD
Family Medicine — Payments: $5,861
Family Medicine $5,861